✦ LIBER ✦

Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC)

✍ Scribed by Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Diaz, Jose R.; Kleijnen, Jos; Rea, Daniel W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN15 SYSTEMATIC REVIEW OF LAPATINIB PLU

✍ R Riemsma; CA Forbes; M Amonkar; K Lykopoulos; JR Diaz; J Kleijnen; DW Rea 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

5048 A Q-TWiST analysis of lapatinib plu

✍ B. Sherrill; M. Amonkar; B. Sherif; J. Maltzman; L. O'Rourke; S. Johnston 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Quality-adjusted survival analysis of fi

✍ Sherrill, Beth; Sherif, Bintu; Amonkar, Mayur M.; Maltzman, Julie; O’Rourke, Lis 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 497 KB

Lapatinib or trastuzumab in combination

✍ Sally Doss; Janet Robertson; Jane Adam 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 42 KB

Higher efficacy of letrozole in combinat

✍ J. Huober; P.A. Fasching; M. Barsoum; L. Petruzelka; D. Wallwiener; C. Thomssen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 350 KB

PCN97 A COST-UTILITY ANALYSIS ON THE USE

✍ S McNamara; L Moore; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB